Nesina (alogliptin) is an oral medication for type 2 diabetes. Coinciding with the launch into the Canadian market, concepts were created highlighting the benefits of affordability in a DPP-4 inhibitor treatment for type 2 diabetes patients. Adopting a less clinical and more lighthearted visual tone than what's often used within the healthcare/pharma space, I provided art direction, design and illustration for a series of playful journal ad concepts. Created with the team at Healthwise Creative Resource Group, Toronto for Takeda.
Back to Top